Leukapheresis: bulk lymphocytes for characterisation of HIV persistence
| Study type |
Summary |
Inclusion Criteria |
Participation requirements |
Status |
| Observational/laboratory based study | The leukapheresis study involves detailed investigation of white blood cells from HIV+ participants, aiming to characterise virus-containing cell populations, whether the virus is infectious and if latency-reversing agents can be used to activate the virus. |
|
Eligible participants attend 2-3 clinic visits before the leukapheresis procedure (including one education session). Leukapheresis involves taking large amounts of blood out of one vein, removing the white blood cells via an automated cell separator and transfusing the rest of the blood back into another vein. It takes 3-4 hours. | Currently recruiting |
Study contact
Alfred Clinical Research Unit on 03 9076 6908
.png)